BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12297423)

  • 1. IRAK-4 as the central TIR signaling mediator in innate immunity.
    Suzuki N; Suzuki S; Yeh WC
    Trends Immunol; 2002 Oct; 23(10):503-6. PubMed ID: 12297423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
    Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
    J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRAK-M is a negative regulator of Toll-like receptor signaling.
    Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
    Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members.
    Janssens S; Beyaert R
    Mol Cell; 2003 Feb; 11(2):293-302. PubMed ID: 12620219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyogenic bacterial infections in humans with IRAK-4 deficiency.
    Picard C; Puel A; Bonnet M; Ku CL; Bustamante J; Yang K; Soudais C; Dupuis S; Feinberg J; Fieschi C; Elbim C; Hitchcock R; Lammas D; Davies G; Al-Ghonaium A; Al-Rayes H; Al-Jumaah S; Al-Hajjar S; Al-Mohsen IZ; Frayha HH; Rucker R; Hawn TR; Aderem A; Tufenkeji H; Haraguchi S; Day NK; Good RA; Gougerot-Pocidalo MA; Ozinsky A; Casanova JL
    Science; 2003 Mar; 299(5615):2076-9. PubMed ID: 12637671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
    Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
    Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide.
    Hu J; Jacinto R; McCall C; Li L
    J Immunol; 2002 Apr; 168(8):3910-4. PubMed ID: 11937546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
    Medzhitov R; Preston-Hurlburt P; Kopp E; Stadlen A; Chen C; Ghosh S; Janeway CA
    Mol Cell; 1998 Aug; 2(2):253-8. PubMed ID: 9734363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88 as a bottle neck in Toll/IL-1 signaling.
    Takeuchi O; Akira S
    Curr Top Microbiol Immunol; 2002; 270():155-67. PubMed ID: 12467250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of innate immune signaling by IRAK proteins.
    Pereira M; Gazzinelli RT
    Front Immunol; 2023; 14():1133354. PubMed ID: 36865541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.
    O'Neill L
    Biochem Soc Trans; 2000 Oct; 28(5):557-63. PubMed ID: 11044374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses.
    Suzuki N; Chen NJ; Millar DG; Suzuki S; Horacek T; Hara H; Bouchard D; Nakanishi K; Penninger JM; Ohashi PS; Yeh WC
    J Immunol; 2003 Apr; 170(8):4031-5. PubMed ID: 12682231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling.
    Bin LH; Xu LG; Shu HB
    J Biol Chem; 2003 Jul; 278(27):24526-32. PubMed ID: 12721283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
    Janssens S; Burns K; Tschopp J; Beyaert R
    Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes.
    Muzio M; Polentarutti N; Bosisio D; Prahladan MK; Mantovani A
    J Leukoc Biol; 2000 Apr; 67(4):450-6. PubMed ID: 10770275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.